Rare Cancers: Sarcomas, Neuroendocrine tumors, Pediatric cancers.

Rare cancers such as sarcomas and neuroendocrine tumors present unique challenges due to their low incidence and heterogeneity. Sarcoma research emphasizes the identification of genetic mutations and the development of targeted therapies, including tyrosine kinase inhibitors. Neuroendocrine tumors benefit from advancements in imaging techniques and peptide receptor radionuclide therapy (PRRT), improving precision treatment. Pediatric cancers, though rare, receive focused attention in developing age-appropriate therapies with minimal long-term toxicity. Efforts in international collaborations and funding are crucial to advancing rare cancer research, ensuring improved diagnostics, treatment options, and survivorship care.